Literature DB >> 11158772

Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.

F Fitoussi1, C Doit, P Geslin, N Brahimi, E Bingen.   

Abstract

The genetic basis of macrolide resistance was investigated in a collection of 48 genotypically unrelated clinical isolates of Streptococcus pneumoniae obtained between 1987 and 1997 in France. All strains were resistant to erythromycin, clindamycin, and streptogramin B, exhibiting a macrolide-lincosamide-streptogramin B resistance phenotype, and harbored the erm(B) gene. None of the strains carried the mef(A) or erm(A) subclass erm(TR) gene.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11158772      PMCID： PMC90344          DOI： 10.1128/AAC.45.2.636-638.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  24 in total

Review 1.  Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae.

Authors:  N J Johnston; J C De Azavedo; J D Kellner; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

3.  Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens.

Authors:  F Baquero; J A García-Rodríguez; J García de Lomas; L Aguilar
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

4.  Characterization of a plasmid determining resistance to erythromycin, lincomycin, and vernamycin Balpha in a strain Streptococcus pyogenes.

Authors:  D B Clewell; A E Franke
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

5.  Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes.

Authors:  J Clancy; J Petitpas; F Dib-Hajj; W Yuan; M Cronan; A V Kamath; J Bergeron; J A Retsema
Journal:  Mol Microbiol       Date:  1996-12       Impact factor: 3.501

6.  Detection of erythromycin-resistant determinants by PCR.

Authors:  J Sutcliffe; T Grebe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

7.  mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae.

Authors:  A Tait-Kamradt; J Clancy; M Cronan; F Dib-Hajj; L Wondrack; W Yuan; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

8.  A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes.

Authors:  H Seppälä; M Skurnik; H Soini; M C Roberts; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

9.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

10.  Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa.

Authors:  C A Widdowson; K P Klugman
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883
View more
  16 in total

1.  Mechanisms of macrolide resistance in clinical group B streptococci isolated in France.

Authors:  F Fitoussi; C Loukil; I Gros; O Clermont; P Mariani; S Bonacorsi; I Le Thomas; D Deforche; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Phenotypes and genotypes of erythromycin-resistant pneumococci in Italy.

Authors:  Maria Pia Montanari; Marina Mingoia; Ileana Cochetti; Pietro Emanuele Varaldo
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

3.  Genetic basis of antibiotic resistance in Streptococcus agalactiae strains isolated in a French hospital.

Authors:  Claire Poyart; Laurence Jardy; Gilles Quesne; Patrick Berche; Patrick Trieu-Cuot
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

4.  Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002.

Authors:  Jean-Winoc Decousser; Patrick Pina; Florent Viguier; Franc Picot; Patrice Courvalin; Pierre Allouch
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 5.  Molecular detection of the macrolide efflux gene: to discriminate or not to discriminate between mef(A) and mef(E).

Authors:  Corné H W Klaassen; Johan W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

6.  Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of seven-valent pneumococcal Vaccination for French children.

Authors:  Farah Mahjoub-Messai; Catherine Doit; Jean-Louis Koeck; Typhaine Billard; Bénédicte Evrard; Philippe Bidet; Christine Hubans; Josette Raymond; Corinne Levy; Robert Cohen; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

7.  Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae.

Authors:  M Del Grosso; F Iannelli; C Messina; M Santagati; N Petrosillo; S Stefani; G Pozzi; A Pantosti
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

8.  Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe.

Authors:  Ralf René Reinert; Adrian Ringelstein; Mark van der Linden; Murat Yücel Cil; Adnan Al-Lahham; Franz-Josef Schmitz
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

9.  In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides.

Authors:  Edward O Mason; Linda B Lamberth; Ellen R Wald; John S Bradley; William J Barson; Sheldon L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

10.  Antimicrobial resistance of invasive pneumococci in Finland in 1999-2000.

Authors:  Marja Pihlajamäki; Jari Jalava; Pentti Huovinen; Pirkko Kotilainen
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.